These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27876665)

  • 21. Prerandomization: an alternative to classic randomization. The effects on recruitment in a controlled trial of arthroscopy for osteoarthrosis of the knee.
    Chang RW; Falconer J; Stulberg SD; Arnold WJ; Dyer AR
    J Bone Joint Surg Am; 1990 Dec; 72(10):1451-5. PubMed ID: 2254351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing medical and educational intervention studies. A review of some alternatives to conventional randomized controlled trials.
    Bradley C
    Diabetes Care; 1993 Feb; 16(2):509-18. PubMed ID: 8432226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment.
    Faseru B; Mussulman LM; Nazir N; Ellerbeck EF; Shergina E; Scheuermann TS; Gajewski BJ; Catley D; Richter KP
    Subst Abus; 2022; 43(1):1035-1042. PubMed ID: 35435813
    [No Abstract]   [Full Text] [Related]  

  • 25. Dynamic balanced randomization for clinical trials.
    Signorini DF; Leung O; Simes RJ; Beller E; Gebski VJ; Callaghan T
    Stat Med; 1993 Dec; 12(24):2343-50. PubMed ID: 8134737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons to be learnt from the International Subarachnoid Haemorrhage Trial (ISAT).
    Kirkpatrick PJ; Kirollos RW; Higgins N; Matta B
    Br J Neurosurg; 2003 Feb; 17(1):5-7. PubMed ID: 12779191
    [No Abstract]   [Full Text] [Related]  

  • 27. [The need for uncertainty in clinical research. Equipoise].
    Rodrigues HC; Oerlemans AJ; van den Berg PP
    Ned Tijdschr Geneeskd; 2011; 155(49):A3846. PubMed ID: 22166179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The irrelevance of equipoise.
    Veatch RM
    J Med Philos; 2007; 32(2):167-83. PubMed ID: 17454421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Critical analysis of types and objectives of phamacological trials].
    Juhos V
    Ideggyogy Sz; 2011 Sep; 64(9-10):325-7. PubMed ID: 22059369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A closer look at the bad deal trial: beyond clinical equipoise.
    Jansen LA
    Hastings Cent Rep; 2005; 35(5):29-36. PubMed ID: 16295262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials in the new millennium.
    DeMets DL
    Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic beneficence and patient recruitment in randomized controlled clinical trials.
    Mann H
    Am J Bioeth; 2002; 2(2):35-6. PubMed ID: 12189074
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethical dilemmas regarding treatment when recruitment ends in randomized trials.
    Mavroforou A; Giannoukas AD; Gaines P; Michalodimitrakis E; Beard JD
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):571-2. PubMed ID: 15531189
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fallibility: a new perspective on the ethics of clinical trial enrollment.
    Shamy MC; Stahnisch FW; Hill MD
    Int J Stroke; 2015 Jan; 10(1):2-6. PubMed ID: 25491546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An easily customized, random allocation system using the minimization method for multi-institutional clinical trials.
    Kenjo Y; Antoku Y; Akazawa K; Hanada E; Kinukawa N; Nose Y
    Comput Methods Programs Biomed; 2000 May; 62(1):45-9. PubMed ID: 10699684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care.
    Eldridge SM; Ashby D; Feder GS
    Clin Trials; 2005; 2(2):91-8. PubMed ID: 16279130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control group selection in critical care randomized controlled trials evaluating interventional strategies: An ethical assessment.
    Silverman HJ; Miller FG
    Crit Care Med; 2004 Mar; 32(3):852-7. PubMed ID: 15090973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ethical problem of randomization.
    Colli A; Pagliaro L; Duca P
    Intern Emerg Med; 2014 Oct; 9(7):799-804. PubMed ID: 25194693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.